Head-to-head · WeighScore
Trimi vs Tuyo Health
By GLP-1 ScorecardUpdated
Score comparison
Trimi has the higher recorded score — 86.4/100 to 72.5/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trimi combines compounded injections and care in monthly or prepaid plans; the annual discount is substantial, but prescription-issued refund limits deserve equal attention.
Before you choose
Before comparing the headline prices, the Trimi review and the Tuyo Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Trimi vs UR Meds and TrueMe vs Tuyo Health compare each of them with another graded program, and the list of alternatives to Trimi ranks the programs closest to Trimi on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the bmiMD review covers one graded close to these two, at 79.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Trimi | Tuyo Health |
|---|---|---|
| WeighScore | 86.4/100 | 72.5/100 |
| Grade | B | C |
| Site position | #8 | #88 |
| Semaglutide | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) | GLP-1 plans from $155/mo; confirm the selected drug and renewal |
| Tirzepatide | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) | Drug-specific price not disclosed |
| Coverage | All 50 states | Confirm treatment-specific availability |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #8 · B
Strengths
- Separate semaglutide and tirzepatide plans include prescribed medication and care
- Monthly, quarterly, six-month and annual charges published
- BelieveRx pharmacy and Arora Health care network publicly named; individual assignment and licenses still need confirmation
- Supplies and shipping included under the published offer
What to consider
- Compounded injections only; no current branded or oral route
- Monthly and quarterly plans renew automatically; six-month and annual continuation needs a new confirmed purchase
- Ordinary orders become nonrefundable once the prescription is issued, even before shipping
- A named pharmacy partner does not independently verify the pharmacy assigned to your order
FDAWarning letter issued to Tuyo Health, Inc. dba Tuyo Health in September 2025. See the FDA warning-letter database.
Strengths
- Public terms explain the renewal cancellation deadline and participating-pharmacy billing
What to consider
- Public starting figure does not establish a medication-specific price or refill schedule
- Assigned pharmacy and coverage depend on the selected plan
- FDA issued Tuyo Health, Inc. dba Tuyo Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.